Автор туралы ақпарат

Юренева, Светлана Владимировна

Шығарылым Бөлім Атауы Файл
№ 3 (2011) Articles OPTIMIZATION OF ANTIRESORPTIVE THERAPY WITH BISPHOSPHONATES
№ 5 (2012) Articles THE CLINICAL AND PROGNOSTIC VALUE OF HYPOVITAMINOSIS D IN POSTMENOPAUSAL OSTEOPOROSIS
№ 11 (2013) Articles PATHOGENETIC BASES FOR THE DEVELOPMENT OF AN ACUTE PHASE RESPONSE TO INTRAVENOUS ADMINISTRATION OF NITROGEN-CONTAINING BISPHOSPHONATES
№ 2 (2014) Articles Vaginal atrophy
№ 3 (2014) Articles FEMALE REPRODUCTIVE SYSTEM AGING: FROM THEORY TO CLINICAL PRACTICE PART 1. THE ENDOCRINE AND CLINICAL CHARACTERISTICS OF FEMALE REPRODUCTIVE SYSTEM AGING STAGES
№ 4 (2014) Articles Female reproductive system aging: From theory to clinical practice. Part 2. Role of hormone therapy in solving the problems of transition stage and early postmenopause
№ 8 (2014) Articles Non-instrumental screening for low bone mineral density in women with secondary amenorrhea
№ 11 (2014) Articles Prevalence of vulvovaginal atrophy and its impact on quality of life in women. The issues of terminology and the safety of local hormone therapy
№ 6 (2015) Articles OPTIMIZATION OF MENOPAUSAL HORMONE THERAPY-RELATED RISKS: THERAPY WITH TRANSDERMAL ESTROGENS ALONE OR IN COMBINATION WITH MICRONIZED PROGESTERONE. ADVANTAGES AGAINST METABOLIC RISKS AND ARTERIAL THROMBOSIS
№ 5 (2015) Articles OPTIMIZATION OF MENOPAUSAL HORMONE THERAPY-RELATED RISKS: MONOTHERAPY WITH TRANSDERMAL ESTROGENS OR IN COMBINATION WITH MICRONIZED PROGESTERONE. ADVANTAGES AGAINST VENOUS THROMBOEMBOLISM AND BREAST CANCER
№ 12 (2015) Articles VULVOVAGINAL ATROPHY: SYMPTOMS, IMPACT ON EMOTIONAL WELL-BEING, QUALITY, AND SEXUAL FUNCTION
№ 6 (2016) Articles Alternative methods for the treatment of vasomotor symptoms in postmenopausal women
№ 5 (2016) Articles GENITOURINARY SYNDROME OF MENOPAUSE IN PERI- AND POSTMENOPAUSAL PATIENTS: DIAGNOSIS AND THERAPY (short clinical guidelines)
№ 9 (2016) Articles VENOUS THROMBOEMBOLISM AND COMBINED ORAL CONTRACEPTION
№ 3 (2017) Articles Menopausal hormone therapy and risk of coronary heart disease
№ 8 (2017) Articles Role of hypothalamic (trigger) neuropeptides in the genesis of hot flushes. Prospects for new therapeutic approaches to treating vasomotor menopausal symptoms
№ 11 (2017) Articles Menopausal hormone therapy and cervical cancer: A current view of the problem
№ 4 (2018) Articles Characteristics of risk factors for dementia in women: a possible preventive role of menopausal hormone therapy
№ 6 (2018) Articles Evolution of the goals of menopausal hormone therapy. From treatment for hot flushes to the new horizons of cardiometabolic protection
№ 1 (2019) Articles Menopausal vasomotor symptoms: social aspects, dynamics, cardiometabolic risks, hormone therapy options
№ 5 (2019) Articles Menopause, obesity, and comorbidity: possibilities of menopausal hormone therapy
№ 11 (2019) Articles Relationship between the symptoms of vulvovaginal epithelial atrophy and the vaginal microbiota in postmenopausal women
№ 11 (2019) Articles The role of neurokinin B in the pathophysiological mechanisms of vasomotor symptoms and sleep disturbances in postmenopausal women
№ 2 (2020) Articles Weight gain in perimenopausal women: methods for assessing the body composition and maintenance tactics
№ 2 (2020) Articles Management of menopausal women with a history of endometriosis
№ 3 (2020) Articles Risk and benefits of menopausal hormonal therapy
№ 12 (2020) Articles The role of lipids determined by a mass spectrometry method in the development of cardiometabolic diseases in menopausal women
№ 6 (2021) Articles Surgical menopause as a risk factor for the early development of comorbid conditions in reproductive-aged women
№ 9 (2021) Articles Menopausal hormone therapy for rheumatic diseases (gout)
№ 12 (2021) Articles Menopausal hormone therapy for rheumatic diseases: osteoarthritis
№ 8 (2022) Articles Impact of menopausal hormone therapy on the development and progression of cervical and endometrial cancers
№ 11 (2021) Articles Evaluation of patients’ satisfaction with Angeliq Micro in real clinical practice after 13 cycles of treatment in Russia
№ 10 (2022) Articles Analysis of treatment satisfaction in patients with premature ovarian failure
№ 6 (2022) Articles Changes in serum lipid profile during the menopausal transition
№ 11 (2022) Articles Contraception in cancer survivors: Breast and gynecological cancers (Part I)
№ 12 (2022) Articles Contraception in patients with a history of cancer: skin, gastrointestinal, hematological, and endocrine cancers (Part II)
№ 11 (2022) Articles Pathogenic variants in the BRCA 1 and BRCA2 genes: what is important for a practicing gynecologist to know
№ 2 (2022) Articles Diagnostic value of anthropometric characteristics of obesity in women during the menopause transition
№ 10 (2016) Articles POSSIBILITIES OF LOW-DOSE LOCAL ESTRIOL THERAPY IN POSTMENOPAUSAL WOMEN WITH VULVOVAGINAL ATROPHY
№ 6 (2017) Articles THERAPY FOR VULVOVAGINAL ATROPHY IN POSTMENOPAUSAL WOMEN: CLINICAL AND PATHOGENETIC ASPECTS
№ 4 (2023) Reviews Impact of hormone therapy on the overall and relapse-free survival of patients receiving treatment for ovarian cancer
№ 4 (2023) Original Articles Impact of menopausal hormone therapy on immune system parameters
№ 5 (2023) Original Articles Quality of life in patients with premature ovarian insufficiency treated with hormone replacement therapy
№ 6 (2023) Reviews Impact of systemic menopausal hormone therapy on symptoms of urinary incontinence in postmenopausal women
№ 8 (2023) Clinical Notes Resolution of the Council of Experts in obstetrics-gynecology, dermatovenerology, gastroenterology and microbiology "Principles of intimate hygiene in healthy women and in vulvar diseases"
№ 11 (2023) Clinical Notes Russian eligibility criteria for menopausal hormone therapy in patients with cardiovascular and metabolic diseases

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>